Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Livtencity
Pharma
Merck's Prevymis outdoes Roche's Valcyte in toxicity measure
In testing Merck's Prevymis against Roche’s Valcyte in kidney transplant recipients, Prevymis showed comparable efficacy and a better safety profile.
Kevin Dunleavy
Oct 24, 2022 10:45am
Gilead's Yescarta 2L DLBCL bid among winners at EMA
Sep 16, 2022 11:25am
Takeda braces for Vyvanse's blockbuster patent loss
May 11, 2022 10:25am
Takeda's CMV drug wins FDA approval
Nov 24, 2021 11:00am
